Add Company
Join Now

Context Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Context Therapeutics's estimated annual revenue is currently $4M per year.(i)
  • Context Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Context Therapeutics has 26 Employees.(i)
  • Context Therapeutics grew their employee count by 100% last year.

Context Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Chief Legal OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Legal Officer & Corporate SecretaryReveal Email/Phone
5
SVP OperationsReveal Email/Phone
6
Senior Director QualityReveal Email/Phone
7
Program Management Consultant at Context TherapeuticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$7.1M4677%N/AN/A
#3
$14.4M9327%N/AN/A
#4
$0.9M60%N/AN/A
#5
$1.6M1043%N/AN/A
#6
$11.5M746%N/AN/A
#7
$0.9M1122%N/AN/A
#8
$3.7M24-8%N/AN/A
#9
$2M1318%N/AN/A
#10
$9.3M602%N/AN/A
Add Company

What Is Context Therapeutics?

Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat female hormone-dependent cancers. Context’s lead program is onapristone extended release (ONA-XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) breast, endometrial, and ovarian cancers.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

100%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M26N/AN/A
#2
$2.6M26-10%N/A
#3
$15M2618%N/A
#4
$2.7M2624%N/A
#5
$3.2M264%N/A